NEW YORK (
CHANGE IN RATINGS
Abercrombie & Fitch
was downgraded to Market Perform at Wells Fargo. Estimates were also cut, given lower comp sales trends, Wells Fargo said.
was upgraded at Bank of America/Merrill Lynch from Neutral to Buy. $37 price target. Company can deliver above-average growth over the next few years, BofA/Merrill said.
was initiated with a Hold rating at Wunderlich. $68 price target. Company operates in a slow-growth market, where supply has caught up with demand, Wunderlich said.
was downgraded at Keybanc from Buy to Hold. Company lacks near-term catalysts, Keybanc said.
was upgraded at Sterne Agee from Underperform to Neutral. Valuation call, based on a $15 price target, Sterne Agee said.
was downgraded to Sell at TheStreet Ratings.
was upgraded to Buy at TheStreet Ratings.
was downgraded at Goldman Sachs from Buy to Neutral. Company is facing increased competition, which could impede growth, Goldman said. $24 price target.
was upgraded at Caris & Company from Average to Buy. $86 price target. Company has strong fundamentals and no longer appears to be on the radar of David Einhorn, Caris said.
Helmerich & Payne
was upgraded at Argus from Hold to Buy, Argus said. $55 price target. Valuation call, as the stock is down about 25% year-to-date, Argus said.
was initiated with a Buy rating at Wunderlich. $20 price target. Company has resumed solid earnings growth, Wunderlich said.
was upgraded at Citigroup to Buy from Neutral following capital plan including deleveraging and new buyback, Citigroup said. $32.50 price target. Company also added to TPL!.
was downgraded from Buy to Neutral at MKM Partners. $16.50 price target. Company is launching new products into a difficult macro environment, MKM said.
was initiated with a Buy rating at Benchmark. $45 price target. Company has good visibility and more than 50% recurring revenue, Benchmark said.
was downgraded at Deutsche Bank to Hold. Company lacks near-term catalysts. $54 price target.
STOCK COMMENTS / EPS CHANGES
Abercrombie & Fitch numbers were cut at UBS. Shares are now seen reaching $60. Estimates were also lowered as European weakness continues, especially at Hollister, UBS said. Buy rating.
Abercrombie & Fitch numbers were cut at Citigroup. Shares are now seen reaching $47. Estimates were also lowered given Europe overhang, Citi said. Company removed from TPL!.
estimates were raised at Oppenheimer through 2012. Expect positive trends to continue, Oppenheimer said. Perform rating.
estimates were raised at Jefferies through 2013. Mark NA sales expectations to market, Jefferies said. Hold rating.
estimates, price target were boosted at Goldman Sachs. Shares are seen reaching $76. Estimates were also increased, given strong operating momentum, Goldman said. Buy rating.
price target was lowered at UBS to $29. Reducing price target to reflect decreased visibility, UBS said. Neutral rating.
numbers were raised at Keefe, Bruyette, Woods. Shares are now seen reaching $34. Estimates were also increased, given the company's new buyback, KBW said. Outperform rating.
estimates, price target reduced at Morgan Stanley. Shares are now seen reaching $18. Estimates were also cut, given slower secular growth trends, Morgan Stanley said. Overweight rating.
was removed from the Conviction Buy List at Goldman Sachs. Valuation call, as the stock is up 47% over the past year, Goldman said. $135 price target.
numbers were increased at Morgan Stanley. Estimates were increased through 2014. Alabama and Canadian assets should drive growth over the coming quarters, Morgan Stanley said. Overweight rating and $90 price target.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
This article was written by a staff member of TheStreet.